|Title:||Introduction of High-Cost Health Technologies|
|Document ID:||Operational Directive OD 0541/14|
|Date of issue:||Thursday, 31 July 2014|
|Status:||NO LONGER APPLICABLE|
|Description:||The purpose of this Operational Directive is to provide a statewide framework for the evaluation of high-cost health technologies and their introduction into clinical practice.|
|Applicable to:||WA Public Health System|
|Framework:||Clinical Governance, Safety and Quality Policy Framework|
|Period of effect:||from 1 July 2014 to 1 July 2019|
|Review date:||1 July 2019|
|Authorised by:||Professor Bryant Stokes, A/Director General, Department of Health WA, 16-Jul-2014|
|Print version:||View print version|
Introduction of High-Cost Health Technologies
The purpose of this Operational Directive is to provide a statewide framework for the evaluation of high-cost health technologies and their introduction into clinical practice.
This sets out the requirement for hospitals and Health Services to seek evaluation by the WA Policy Advisory Committee on Technology (WAPACT) for new high-cost health technologies expected to exceed $250,000 in annual or single acquisition (capital) costs.
Technologies expected to exceed $1 million in annual or capital costs, evaluated as high-risk, or identified by WAPACT to warrant consideration as a statewide service, will be evaluated by WAPACT and referred to the State Health Executive Forum Operations Review Committee (SHEF ORC) for consideration.
All hospitals and Health Services will maintain local policies and guidelines to address health technologies that fall under the $250,000 threshold. This may involve the establishment of health technology assessment (HTA) committees, to assess and approve submissions to WAPACT and to consider technologies below this threshold.
As defined by the Policy for the Introduction of High-Cost Health Technologies, technologies considered by WAPACT include procedures, diagnostics and devices. Pharmaceuticals and information communication technologies are, in general, outside the scope of the policy.
Professor Bryant Stokes
This circular last updated: Thursday, 31 July 2014 at 10:01am